Placebo-Controlled Study of the D<sub>4</sub>/5-HT<sub>2A</sub> Antagonist Fananserin in the Treatment of Schizophrenia - Concepedia

Concepedia

Publication | Closed Access

Placebo-Controlled Study of the D<sub>4</sub>/5-HT<sub>2A</sub> Antagonist Fananserin in the Treatment of Schizophrenia

92

Citations

13

References

1999

Year

Philippe Truffinet, Carol A. Tamminga, Louis F. Fabre, Herbert Y. Meltzer, Marie-Emmanuelle Riviï¿ ⁄ re, Catherine Papillon-Downey

American Journal of Psychiatry

Abstract

The results of this study do not support the prediction that a selective D4 antagonist associated with strong 5-HT2A antagonism will exhibit an antipsychotic effect.

References

	Year	Citations

Page 1